Journal ArticleOPEN ACCESS

Trastuzumab (Herceptin)

American Journal of Neuroradiology (2011) 32(8) 1373-1374
DOI: 10.3174/ajnr.A2619
56Citations
Citations of this article
172Readers
Mendeley users who have this article in their library.

Abstract

Herceptin (trastuzumab) is a human monoclonal antibody that interferes with the HER2 receptor. It is currently the only FDA-approved therapeutic antibody for HER2-positive breast cancer. This article will present the mechanism at action as well as the clinical role at this monoclonal antibody.

Cite

CITATION STYLE

APA

Gemmete, J. J., & Mukherji, S. K. (2011). Trastuzumab (Herceptin). American Journal of Neuroradiology, 32(8), 1373–1374. https://doi.org/10.3174/ajnr.A2619

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free